Many Cancer Survivors Have Conditions Linked to Risk for Severe COVID-19 Illness
WEDNESDAY, Feb. 3, 2021 -- More than half of cancer survivors have underlying medical conditions associated with severe COVID-19 illness, including chronic obstructive pulmonary disease, heart diseases, diabetes, chronic kidney disease, and obesity, according to a study published online Feb. 3 in the Journal of the National Cancer Institute.
Changchuan Jiang, M.D., M.P.H., from the Roswell Park Comprehensive Cancer Center in Buffalo, New York, and colleagues examined the prevalence and sociodemographic factors associated with underlying medical conditions that are linked to an increased risk for severe COVID-19 illness among 6,411 cancer survivors and 77,748 adults without a cancer history.
The researchers found that 56.4 percent of cancer survivors reported having one or more of the conditions (compared with 41.6 percent among adults without a cancer history) and 22.9 percent of survivors reported two or more conditions, representing 8.7 and 3.5 million cancer survivors, respectively. The prevalence of these conditions was increased among survivors of kidney, liver, and uterine cancers and among Black survivors, those with public insurance, and those with low socioeconomic status.
"Underlying medical conditions related to severe COVID-19 illness are common among cancer survivors, highlighting the need to protect this vulnerable population against transmission in health care facilities," the authors write. "Now that safe and effective COVID-19 vaccines are available, cancer patients, survivors, caregivers, and their health care providers should be prioritized in vaccine allocation."
One author disclosed financial ties to AstraZeneca.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Further Support and Information on COVID-19
Read this next
MONDAY, March 1, 2021 -- Walmart said it will expand its COVID-19 vaccination program to more than 1,400 pharmacies in 35 states. The retailer will also partner with local...
MONDAY, March 1, 2021 -- A COVID-19 vaccine still awaiting U.S. Food and Drug Administration approval may prove to be a powerful weapon in fighting the pandemic, according to its...
MONDAY, March 1, 2021 -- The Janssen COVID-19 vaccine received the third emergency use authorization for a vaccine to prevent COVID-19, the U.S. Food and Drug Administration...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.